Murali Doraiswamy

Can a machine truly think the way a human does? According to Dr. P. Murali Doraiswamy—a Duke University professor who has spent decades studying the brain while simultaneously pioneering the use of AI in psychiatry and neurology—the answer is far more nuanced than most technology conversations allow, and understanding the difference is essential for any leader deploying AI. In this presentation, he takes audiences inside the architecture of the human brain—its capacity for intuition, emotional reasoning, and adaptability—and compares it with the pattern-recognition power and inherent limitations of today’s AI systems. Audiences leave understanding what machines do well, what only humans can do, and how leaders can build organizations that harness the best of both.

People are living and working longer than ever, but our understanding of how to sustain the mind across an extended career has not kept pace. Dr. P. Murali Doraiswamy, director of Duke University’s Neurocognitive Disorders Program and one of the world’s foremost Alzheimer’s researchers, has spent his career at this frontier. In this visionary presentation, he explores how advances in AI, precision psychiatry, and digital biomarkers are transforming our ability to detect cognitive decline years before symptoms appear—and how his emerging work on “digital cognitive twins” may soon allow organizations to monitor and protect cognitive health in real time. Audiences leave with a clear picture of where longevity science is headed and what leaders can do now to protect human capability in a world of longer careers and unprecedented cognitive demands.

Most organizations still treat employee wellbeing as a perk rather than a performance strategy. But according to Dr. P. Murali Doraiswamy, a leading physician-scientist at Duke University School of Medicine and former Co-Chair of the World Economic Forum’s Global Future Council on Mental Health, the science tells a different story: constant cognitive overload, longer careers, and rising burnout are silently eroding the decision-making and resilience organizations depend on most. Drawing on decades of clinical experience and neuroscience research and his advisory work with multiple government agencies, businesses and advocacy groups,  Dr. Doraiswamy reveals why brain health is not a personal issue but a strategic priority — and why the organizations that invest in cognitive resilience will consistently outperform those that don’t. Audiences leave with a science-backed framework for building workplaces that sustain peak mental performance at every level.